ATE109510T1 - Pdgf-alpha-rezeptor. - Google Patents

Pdgf-alpha-rezeptor.

Info

Publication number
ATE109510T1
ATE109510T1 AT90908996T AT90908996T ATE109510T1 AT E109510 T1 ATE109510 T1 AT E109510T1 AT 90908996 T AT90908996 T AT 90908996T AT 90908996 T AT90908996 T AT 90908996T AT E109510 T1 ATE109510 T1 AT E109510T1
Authority
AT
Austria
Prior art keywords
pdgf
alpha receptor
disclosed
dna molecules
receptor
Prior art date
Application number
AT90908996T
Other languages
English (en)
Inventor
James D Kelly
Mark J Murray
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE109510T1 publication Critical patent/ATE109510T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT90908996T 1989-05-22 1990-05-21 Pdgf-alpha-rezeptor. ATE109510T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35501889A 1989-05-22 1989-05-22

Publications (1)

Publication Number Publication Date
ATE109510T1 true ATE109510T1 (de) 1994-08-15

Family

ID=23395910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90908996T ATE109510T1 (de) 1989-05-22 1990-05-21 Pdgf-alpha-rezeptor.

Country Status (10)

Country Link
US (2) US5371205A (de)
EP (1) EP0474744B1 (de)
JP (1) JPH04505260A (de)
AT (1) ATE109510T1 (de)
AU (1) AU5749690A (de)
CA (1) CA2057854C (de)
DE (1) DE69011329T2 (de)
DK (1) DK0474744T3 (de)
ES (1) ES2057571T3 (de)
WO (1) WO1990014425A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110737A (en) * 1988-02-02 2000-08-29 The Regents Of The University Of California Human platelet-derived growth factor receptor, type A
US6228600B1 (en) 1992-07-20 2001-05-08 The United States Of America As Represented By The Department Of Health And Human Services Immunoassays for the alpha platelet-derived growth factor receptor
US5468468A (en) * 1989-02-09 1995-11-21 The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services Method for making a monoclonal antibody, monoclonal antibodies to α PD
AU629920B2 (en) * 1989-02-09 1992-10-15 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Type oc platelet-derived growth factor receptor gene
EP0566673A1 (de) * 1990-12-21 1993-10-27 Creative Biomolecules, Inc. Biosynthetische pdgf-antagonisten
US6605442B1 (en) * 1992-03-19 2003-08-12 The Rockefeller University Methods of testing drugs or agents that modulate the activity of receptor recognition factors
US5326695A (en) * 1992-05-15 1994-07-05 Ludwig Institute For Cancer Research Platelet derived growth factor agonists
US5444151A (en) * 1992-05-15 1995-08-22 Ludwig Institute For Cancer Research Platelet derived growth factor antagonists
US5776755A (en) * 1992-10-09 1998-07-07 Helsinki University Licensing, Ltd. FLT4, a receptor tyrosine kinase
US6824777B1 (en) 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
US6107046A (en) * 1992-10-09 2000-08-22 Orion Corporation Antibodies to Flt4, a receptor tyrosine kinase and uses thereof
ATE489108T1 (de) 1998-10-09 2010-12-15 Vegenics Ltd Flt4 (vegfr-3) als ziel für tumornachweis (imaging) und antitumortherapie
US6667173B2 (en) 2000-12-01 2003-12-23 The Schepens Eye Research Institute Nucleic acids encoding platelet derived growth factor-alpha receptors
CA2435503C (en) 2001-01-19 2011-02-22 Ludwig Institute For Cancer Research Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
US7195876B2 (en) 2002-08-09 2007-03-27 Theravance, Inc. Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
EP1574574A4 (de) * 2002-11-15 2005-12-14 Univ Keio Exon 1-beta des gens für pdgf-rezeptor-alpha und verwendung davon
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
WO2005047327A2 (en) 2003-11-12 2005-05-26 Biogen Idec Ma Inc. NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
EP1838736B1 (de) 2005-01-05 2013-03-06 Biogen Idec MA Inc. Cripto-bindende moleküle
DE602006019262D1 (de) * 2005-08-11 2011-02-10 Siemens Healthcare Diagnostics QUANTITATIVE ASSAYS FÜR PDGFR-beta- IN KÖRPERFLÜSSIGKEITEN
TW201217527A (en) 2010-07-09 2012-05-01 Biogen Idec Hemophilia Inc Processable single chain molecules and polypeptides made using same
WO2013012733A1 (en) 2011-07-15 2013-01-24 Biogen Idec Ma Inc. Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto
US9676849B2 (en) 2012-01-10 2017-06-13 Biogen Ma Inc. Enhancement of transport of therapeutic molecules across the blood brain barrier
RS60026B1 (sr) 2013-02-18 2020-04-30 Vegenics Pty Ltd Molekuli koji vezuju ligande i njihove upotrebe
CN115181778A (zh) 2015-02-04 2022-10-14 百时美施贵宝公司 选择治疗性分子的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607306B2 (en) * 1988-02-02 1991-02-28 Regents Of The University Of California, The Human platelet-derived growth factor receptor

Also Published As

Publication number Publication date
DK0474744T3 (da) 1994-11-21
WO1990014425A1 (en) 1990-11-29
DE69011329T2 (de) 1994-12-08
EP0474744A1 (de) 1992-03-18
ES2057571T3 (es) 1994-10-16
CA2057854C (en) 2000-01-11
AU5749690A (en) 1990-12-18
CA2057854A1 (en) 1990-11-23
US5371205A (en) 1994-12-06
JPH04505260A (ja) 1992-09-17
US5618678A (en) 1997-04-08
DE69011329D1 (de) 1994-09-08
EP0474744B1 (de) 1994-08-03

Similar Documents

Publication Publication Date Title
DK0474744T3 (da) PDGF-alfa-receptor
ATE226247T1 (de) Menschliche neuronale nikotin-acetylcholin- rezeptor-verbindungen und methoden ihres einsatzes
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
ATE114724T1 (de) Antikörper gegen tnf-bindungsprotein i und deren f(ab)-fragmente.
YU83600A (sh) Adenozin a3 receptorski modulatori
ATE296348T1 (de) Cytokin lerk-7
NO171223C (no) Monoklonalt reseptormolekyl eller del derav som omfatter det antistoffbindende sete, for in vitro bruk, samt in vitro anvendelse derav
ES2045216T3 (es) Inmunoensayo y derivados polimeros de igg para la compensacion de factores de perturbacion en el inmunoensayo.
DK325189D0 (da) Fremgangsmaade til indfoering af molekyler, isaer genetisk materiale, i cellemateriale samt apparat til anvendelse ved udoevelse af fremgangsmaaden
DE69021564D1 (de) Enzyme und deren verwendung zum nachweis von drogen.
FI901916A7 (fi) Diagnostinen testipakkaus, alukekoostumus, ja näiden käyttö nukleiinihappojen replikaatioon tai havaitsemiseen
DE3580563D1 (de) Nuklearbindungstest fuer steroidrezeptorsfunktion in krebsartigen zellen.
EP0349988A3 (en) Method to determine a specific substance capable of binding
NO882054L (no) Sementblanding, saerlig til bruk i borehull.
DK0862627T3 (da) Neuropeptid Y-Y5 receptor
DE3585049D1 (de) Monoklonale antikoerper.
DK160484C (da) Fiberblanding til forstaerkning af hydrauliske bindemidler, blandingens anvendelse og formdele fremstillet under anvendelse af blandingen.
FI851965A7 (fi) Menetelmä ja laite reseptoreiden aktiivisuuden analysoimiseksi tietyi ssä soluissa.
FI905350A7 (fi) Leimattua streptokokki-vasta-ainetta sisältävä koostumus, testipakkaus ja analyysimenetelmä, jossa sitä käytetään
DK414386D0 (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
IT1274006B (it) Saggio immunologico per analiti in campioni, che utilizza agenti alchilanti
NO984233L (no) Cytokin kalt lerk-8
KR910004251A (ko) 신규의 촉매조성물, 및 이것을 사용하여 모노올레핀을 소중합체화 시키는 방법
NO891756D0 (no) Teststrimler for bestemmelse av urinstoff og deres anvendelse.
ES1024968U (es) Teja perfeccionada.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee